Oligometastatic breast cancer: old to new entity, outcome and treatment algorithm

Bookmark and Share
Published: 31 Jan 2023
Views: 49
Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA

Prof Sandra Swain speaks to ecancer at BGICC 2023 about oligometastatic breast cancer.

She defines the term oligometastatic as the intermediate step between primary breast cancer and metastatic breast cancer and then highlights the theoretical approaches which surround this term.

Prof Swain also outlines key randomised breast cancer studies presented in her BGICC 2023 talk such as the ongoing OLIGOMA trial.